Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden

PaperCitations, authors & open-access status

The Cost-Effective Price of Lecanemab for Patients with Early Alzheimer’s Disease in Sweden is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 3 citations, 2025 year and hybrid oa status.

3
Citations
2025
Year
hybrid
OA Status

Related on ScholarIQ

Sandar Aye
Author
PharmacoEconomics
Journal
Dementia and Cognitive Impairment Research
Topic
Dementia and Cognitive Impairment Research
Topic
Alzheimer's disease research and treatments
Topic
Cholinesterase and Neurodegenerative Diseases
Topic
470M+ articles · free account